RT Journal Article
SR Electronic
T1 654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A745
OP A745
DO 10.1136/jitc-2023-SITC2023.0654
VO 11
IS Suppl 1
A1 Olson, Daniel J
A1 Dumbrava, Ecaterina
A1 George, Mridula
A1 Saibil, Sam
A1 Butler, Marcus
A1 Giordano, Antonio
A1 Pieke, Brooke
A1 Gavriliuc, Miriam
A1 Lichtenstein, Emily
A1 Geisberger, Jill
A1 Apostolopoulou, Maria
A1 Moss, Kara
A1 Kirkwood, D’Arcy
A1 Dang, Salina
A1 Adib, Deyaa
A1 Schlechter, Benjamin
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A745.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.